Manassas, VA – According to filings with the U.S. Securities and Exchange Commission, NotalVision is raising $62,500,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Kester Nahen played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About NotalVision
Notal Vision is a patient-centric ophthalmic digital diagnostic services provider extending age-related macular degeneration (AMD) monitoring from the clinic to the home, providing Eye Care Professionals with remote monitoring services to support their patient care between office visits. With a proven approach to home-based, self-operated diagnostics, AI-enabled data analysis, and patient engagement, we help physicians preserve patients vision. Notal Vision offers a full-service, remote ophthalmic clinic directed by practicing ophthalmologists and supported by a team of certified ophthalmic professionals. The Notal Vision Diagnostic Clinic is a Medicare credentialed healthcare provider offering comprehensive patient training and monitoring between office visits, facilitating a high level of compliance for clinical efficacy. The ForeseeHome AMD Monitoring Program helps physicians detect conversion to wet AMD and pipeline technology, Notal Home OCT, will monitor exudative retinal diseases.

To learn more about NotalVision, visit http://notalvision.com/

Contact:
Kester Nahen, Chief Executive Officer
703-953-3339
kester@notalvision.com
https://www.linkedin.com/in/kester-nahen-phd-ba6a178/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved